Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Maravai LifeSciences Holdings Inc
NASDAQ:MRVI
Price:
3.13
USD
0.32%
Market Cap:
$800.4m
Cash Flow Statement
Cash Flow Statement
Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
79
|
154
|
289
|
357
|
469
|
541
|
563
|
530
|
491
|
343
|
174
|
59
|
(138)
|
(160)
|
(162)
|
(323)
|
(260)
|
(290)
|
(345)
|
(214)
|
|
| Depreciation & Amortization |
26
|
32
|
39
|
25
|
25
|
26
|
27
|
29
|
32
|
33
|
35
|
38
|
40
|
43
|
46
|
53
|
48
|
49
|
50
|
45
|
|
| Change in Deffered Taxes |
(6)
|
6
|
13
|
25
|
47
|
48
|
55
|
53
|
42
|
28
|
12
|
(3)
|
755
|
756
|
759
|
765
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
25
|
27
|
29
|
30
|
10
|
12
|
14
|
15
|
19
|
21
|
26
|
31
|
35
|
41
|
45
|
48
|
49
|
48
|
41
|
37
|
|
| Other Non-Cash Items |
17
|
16
|
21
|
23
|
4
|
8
|
2
|
13
|
16
|
24
|
32
|
44
|
(628)
|
(626)
|
(614)
|
(465)
|
231
|
243
|
271
|
118
|
|
| Cash Taxes Paid |
5
|
8
|
14
|
25
|
23
|
21
|
27
|
26
|
23
|
23
|
9
|
0
|
(3)
|
(4)
|
(3)
|
1
|
1
|
1
|
(0)
|
(1)
|
|
| Cash Interest Paid |
29
|
36
|
43
|
30
|
27
|
21
|
19
|
18
|
20
|
28
|
35
|
41
|
44
|
47
|
48
|
48
|
51
|
45
|
40
|
34
|
|
| Change in Working Capital |
36
|
(18)
|
(5)
|
(41)
|
(177)
|
(131)
|
(155)
|
(130)
|
(45)
|
31
|
61
|
80
|
98
|
19
|
3
|
(0)
|
(13)
|
4
|
2
|
1
|
|
| Cash from Operating Activities |
152
N/A
|
191
+25%
|
356
+87%
|
389
+9%
|
369
-5%
|
493
+34%
|
491
0%
|
495
+1%
|
536
+8%
|
459
-14%
|
314
-32%
|
218
-31%
|
126
-42%
|
33
-74%
|
31
-5%
|
30
-3%
|
7
-75%
|
7
-12%
|
(21)
N/A
|
(49)
-134%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(25)
|
(29)
|
(33)
|
(18)
|
(15)
|
(14)
|
(11)
|
(17)
|
(17)
|
(22)
|
(46)
|
(55)
|
(66)
|
(63)
|
(48)
|
(42)
|
(31)
|
(31)
|
(24)
|
(17)
|
|
| Other Items |
32
|
32
|
32
|
121
|
121
|
(119)
|
(119)
|
(238)
|
(251)
|
(74)
|
(73)
|
(73)
|
(57)
|
7
|
9
|
9
|
7
|
(12)
|
(16)
|
(17)
|
|
| Cash from Investing Activities |
6
N/A
|
3
-46%
|
(1)
N/A
|
103
N/A
|
106
+3%
|
(133)
N/A
|
(130)
+2%
|
(255)
-96%
|
(268)
-5%
|
(96)
+64%
|
(118)
-24%
|
(128)
-8%
|
(122)
+4%
|
(57)
+54%
|
(39)
+32%
|
(32)
+17%
|
(24)
+25%
|
(43)
-78%
|
(40)
+7%
|
(34)
+15%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
301
|
302
|
302
|
303
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(5)
|
(5)
|
(5)
|
|
| Net Issuance of Debt |
197
|
195
|
194
|
179
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(234)
|
(234)
|
(234)
|
(234)
|
|
| Other |
(445)
|
(468)
|
(501)
|
(551)
|
(155)
|
(172)
|
(181)
|
(168)
|
(184)
|
(162)
|
(162)
|
(123)
|
(55)
|
(35)
|
8
|
9
|
0
|
(1)
|
(2)
|
(11)
|
|
| Cash from Financing Activities |
53
N/A
|
29
-45%
|
(5)
N/A
|
(69)
-1 276%
|
(159)
-131%
|
(175)
-10%
|
(185)
-5%
|
(171)
+7%
|
(188)
-10%
|
(166)
+11%
|
(166)
+0%
|
(128)
+23%
|
(61)
+52%
|
(42)
+31%
|
1
N/A
|
1
+12%
|
(236)
N/A
|
(240)
-2%
|
(242)
-1%
|
(251)
-4%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
212
N/A
|
223
+5%
|
350
+57%
|
423
+21%
|
315
-25%
|
184
-42%
|
176
-4%
|
70
-60%
|
81
+16%
|
197
+143%
|
30
-85%
|
(38)
N/A
|
(57)
-51%
|
(67)
-17%
|
(7)
+89%
|
(1)
+80%
|
(253)
-18 188%
|
(277)
-10%
|
(303)
-10%
|
(335)
-10%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
127
N/A
|
162
+28%
|
323
+100%
|
371
+15%
|
354
-5%
|
478
+35%
|
480
+0%
|
479
0%
|
519
+8%
|
437
-16%
|
268
-39%
|
163
-39%
|
61
-63%
|
(31)
N/A
|
(17)
+45%
|
(12)
+31%
|
(24)
-104%
|
(24)
-2%
|
(45)
-87%
|
(67)
-48%
|
|
Switch to:
Switch to:
See Also
Discover More
